SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
latest_posts
- 1
Some super-smart dogs can pick up new words just by eavesdropping - 2What to watch for as NASA’s historic Artemis II crew prepares to lift off toward the moon
- 3IDF strikes Tehran command centers, weapon production sites
- 4Manual for Wonderful Getaway destination
- 5Choosing the Ideal Bed for Quality Rest and Solace
- In wrangling dark matter, some scientists find inspiration in the Torah, Krishna and Christ
- The Main 15 Applications for Efficiency and Association
- Merz: 80% of Syrians in Germany should return in three years
- Step by step instructions to Get a good deal on Your Rooftop Substitution Venture
- The Delight of Perusing: Book Proposals for Each Class
- Very good quality Greens All over The Planet
- Cyclone Narelle turns Australian skies blood red in ‘apocalyptic’ scenes
- Brazil judge orders government to add JBS subsidiary to 'dirty list' for slavery
- Clones of Stumpy, Washington D.C.'s beloved cherry blossom tree, have flowered for the first time
